OS Therapies Incorporated
OSTX · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $62,635 | $47,215 | $32,724 | $529,748 |
| - Cash | $1,876,626 | $2,802 | $2,971 | $5,534 |
| + Debt | $0 | $0 | $0 | $6,050 |
| Enterprise Value | -$1,813,991 | $44,413 | $29,753 | $530,265 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$125 | -$113 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$6,755 | -$4,424 | -$3,876 | -$2,982 |
| % Margin | – | – | – | – |
| Net Income | -$6,880 | -$4,537 | -$3,877 | -$2,991 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.21 | -0.18 | -0.18 | -0.04 |
| % Growth | -16.7% | 0% | -348.9% | – |
| Operating Cash Flow | -$4,706 | -$2,360 | -$3,442 | -$2,375 |
| Capital Expenditures | $0 | -$316 | -$150 | -$0 |
| Free Cash Flow | -$4,706 | -$2,677 | -$3,592 | -$2,375 |